Neurology Trial: 16 week study designed to assess the effect of the drug versus placebo on respiratory function with patients with ALS

INCLUSION: Male/Female 18-80 years of age Sporadic or familial ALS <24 months prior to screening SVC > 65% of predicted for age/height/sex EXCLUSION: At time of screening any use of non-invasive ventilation Neurological impairment due to a condition other than ALS Presence at screening of any medically significant cardiac, pulmonary, gastrointestinal, musculoskeletal, or psychiatric illness […]